PathoGenetix Names Ann Merrifield as Chief Executive Officer and…
Experienced in developing high-growth biotechnology businesses, Merrifield will lead the commercialization of PathoGenetix’s proprietary Genome Sequence Scanning™ (GSS™) technology for application in…(PRWeb December 05, 2012)Read the full st…
PathoGenetix Names Ann Merrifield as Chief Executive Officer and… Read Post »